Access cutting-edge shigellosis treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access shigellosis specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related shigellosis treatment provided free
In this challenge study, the bioconjugate candidate vaccine Shigella4V2 will be tested for its ability to induce an immune response that protects healthy adult volunteers from infection with a wild-type Shigella sonnei strain compared to participants receiving placebo.
Sponsor: LimmaTech Biologics AG
Check if you qualify for this shigellosis clinical trial in Atlanta, GA
If you're searching for shigellosis treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced shigellosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.